Frontlight ResearchEarly access
Active, not recruitingNo phase
Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
Key facts
- Who runs it
- North American Science Associates Ltd.
- Where
- Charlottesville, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 126 people, planned
- Started
- 1 Oct 2025
- Expected to end
- Oct 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- genicular artery embolization
- Corticosteroid Injection
- Record updated
- 12 November 2026
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patient has localized knee pain
- Must be an appropriate candidate for arterial vascular access procedure
Who cannot take part
- Known sensitivity or allergy to implant materials
- Unable or unwilling to comply with study requirements
Where in United States
- University of VirginiaCharlottesville, United States
About the trial
What the trial wants to find out
Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection
The 2 groups in the trial
- ControlExisting treatment, for comparison
Treatment: Corticosteroid Injection
- Device: GAETreatment being tested
Treatment: genicular artery embolization
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Resorbable Embolization MicroSpheres for OsteoaRthritis Benefit
- Record updated
- 12 November 2026